During the past decade, Louisiana Research Center, LLC conducted 73 clinical trials. In the 10-year time frame, 73 clinical trials started and 43 clinical trials were completed, i.e. on average, 58.9% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 31 clinical trials were completed. i.e. 124% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Louisiana Research Center, LLC" #1 sponsor was "Shire" with 13 trials, followed by "Exact Sciences Corporation" with 10 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Takeda" with 7 trials sponsored. Other sponsors include 47 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Louisiana Research Center, LLC" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Allergan Sales, LLC" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator, "Novo Nordisk A/S" with 1 trials as a collaborator and "Pharmaceutical Research Associates" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Louisiana Research Center, LLC" are "Crohn's Disease" (15 trials), "Ulcerative Colitis" (14 trials), "Colorectal Cancer" (12 trials), "Nonalcoholic Steatohepatitis" (7 trials) and "Crohn Disease" (6 trials). Many other conditions were trialed in "Louisiana Research Center, LLC" in a lesser frequency.

Most popular intervention types in "Louisiana Research Center, LLC" are "Drug" (74 trials), "Other" (14 trials), "Diagnostic Test" (5 trials), "Biological" (3 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Etrolizumab" (4 trials), "Filgotinib" (4 trials), "Ontamalimab" (4 trials) and "Lurasidone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Louisiana Research Center, LLC" are 95 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Louisiana Research Center, LLC". undefined are not yet recruiting, 9 are recruiting, 18 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 49 completed trials in Louisiana Research Center, LLC, undefined suspended trials, and 18 terminated clinical trials to date.

Out of the total trials that were conducted in Louisiana Research Center, LLC, 2 "Phase 1" clinical trials were conducted, 23 "Phase 2" clinical trials and 49 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".